A perspective from countries using organized screening programs

Cancer

Volumn 101, Issue 5 SUPPL., 2004, Pages 1201-1213

  Miles, Anne ^a   Cockburn, Jill ^b   Smith, Robert A ^c   Wardle, Jane ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

Early detection; Malignant neoplasms; Opportunistic screening; Organized screening; Population registers; Quality assurance

Indexed keywords

CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EARLY DIAGNOSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INTERVIEW; MEDLINE; MORBIDITY; POPULATION; PRIORITY JOURNAL; REVIEW; TUMOR BIOPSY;

EID: 4143116827     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20505     Document Type: Review

References (79)

1. Pedersen KE, Elwood M. Current international developments in population screening for colorectal cancer. Aust N Z J Surg. 2002;72:507-512.
2. National Center for Chronic Disease Prevention and Health Promotion. Behavioral risk factor surveillance system [database online]. Available from URL: http://www.cdc.gov/brfss [accessed Nov 11, 2003].
3. Cuzick J, Sasieni P. Cervical screening in the United Kingdom. Hong Kong Med J. 1999;5:269-271.
4. Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ. 1994;309:241-248.
5. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999;91: 1641-1646.
6. Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European Union. Eur J Cancer. 2000;36:1473-1478.
7. Calman K. Developing screening in the NHS. J Med Screen. 1994;2:101-105.
8. Gray JA. Evidence-based screening in the United Kingdom. Int J Technol Assess Health Care. 2001;17:400-408.
9. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA. 2003;290:2129-2137.
10. Torgerson DJ, Donaldson C. An economic view of high compliance as a screening objective. BMJ. 1994;308:117-119.
11. Vainio H, Bianchini F, editors. IARC handbooks of cancer prevention. Volume 7: Breast cancer screening. Lyon: IARC Press, 2002.
12. Watt S. [The cost of screening for breast and cervical cancer in France]. Bull Cancer. 2003;90:997-1004.
13. Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. Eur J Cancer. 2002;38:1458-1464.
14. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003;89:88-93.
15. Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19:243-250.
16. Giles GG, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol. 2003; 14:1209-1211.
17. Idestrom M, Milsom I, Andersson-Ellstrom A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years. Acta Obstet Gynecol Scand. 2002;81:962-967.
18. Sin JP, St. Leger AS. Interventions to increase breast screening uptake: do they make any difference? J Med Screen. 1999;6:170-181.
19. McGahan CE, Blanks RG, Moss SM. Reasons for variation in coverage in the NHS cervical screening programme. Cytopathology. 2001;12:354-366.
20. Millett C, Bardsley M, Binysh K. Exploring the effects of population mobility on cervical screening coverage. Public Health. 2002;116:353-360.
21. Australian Institute of Health and Welfare. BreastScreen Australia achievement report 1997 and 1998 [monograph online]. Available from URL: http://www.aihw.gov.au/publications/can/bsa97-8/#s01 [accessed Nov 11, 2003].
22. NSW Cervical Screening Program and the NSW Pap Test Register. Annual statistical report 2001. Westmead Hospital, Sydney, 2002. Available from URL: http://www.csp. nsw.gov.au [accessed April 2004].
23. Cockburn J, Sutherland M, Cappiello M, Hevern M. Predictors of attendance at a relocatable mammography service for rural women. Aust N Z J Public Health. 1997;21:739-742.
24. Shelley JM, Irwig LM, Simpson JM, Macaskill P. Who has Pap smears in New South Wales? Patterns of screening across sociodemographic groups. Aust J Public Health. 1994;18: 406-411.
25. Stark CR, Reay L, Shiroyama C. The effect of access factors on breast screening attendance on two Scottish islands. Health Bull (Edinb). 1997;55:316-321.
26. Straton JA, Holman CD, Edwards BM. Cervical cancer screening in Western Australia in 1992: progress since 1983. Med J Aust. 1993;159:657-661.
27. Wain G, Morrell S, Taylor R, Mamoon H, Bodkin N. Variation in cervical cancer screening by region, socio-economic, migrant and indigenous status in women in New South Wales. Aust N Z J Obstet Gynaecol. 2001;41:320-325.
28. NHS Breast Screening Programme. Report of the UKCCCR/NHSBSP Workshop. Breast screening acceptability: research and practice. NHSBSP Publication No. 28. 2003.
29. Kee F, Telford AM, Donaghy P, O'Doherty A. Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev. 1992;1:311-315.
30. Schofield PE, Cockburn J, Hill DJ, Reading D. Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies. J Med Screen. 1994;1:144-149.
31. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health. 1994;48:65-73.
32. Sutton S, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom Flexible Sigmoidoscopy Screening Trial. J Med Screen. 2000;7:99-104.
33. King J, Fairbrother G, Thompson C, Morris DL. Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust N Z J Surg. 1992;62:714-719.
34. Stead MJ, Wallis MG, Wheaton ME. Improving uptake in non-attenders of breast screening: selective use of second appointment. J Med Screen. 1998;5:69-72.
35. Turner KM, Wilson BJ, Gilbert FJ. Improving breast screening uptake: persuading initial non-attenders to attend. J Med Screen. 1994;1:199-202.
36. Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:346-354.
37. Banks E, Beral V, Cameron R, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002;4:R1.
38. Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening - a focus group study among women in Sweden. Eur J Cancer Prev. 2001;10:429-442.
39. Matson S, Andersson I, Berglund G, Janzon L, Manjer J. Nonattendance in mammographic screening: a study of intraurban differences in Malmo, Sweden, 1990-1994. Cancer Detect Prev. 2001;25:132-137.
40. Government Statistical Service. Cervical screening programme, England: 2001-02 [monograph online]. Available from URL: http://www.publications.doh.gov. uk/public/sb0221.htm laccessed Mar 25, 2004].
41. Challier B, Meslans Y, Viel JF. Deprived areas and attendance to screening of cervix uteri cancer in a French region. Cancer Causes Control. 2000;11:157-162.
42. Eaker S, Adarni HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med. 2001;32:482-491.
43. Eaker S, Adami HO, Sparen P. Attitudes to screening for cervical cancer: a population-based study in Sweden. Cancer Causes Control. 2001;12:519-528.
44. UK CRC Screening Pilot Evaluation Team. Evaluation of the UK Colorectal Cancer Screening Pilot [monograph online]. Available from URL: http://cancerscreening.org.uk/colorectal/pilot-evaluation.html [accessed Mar 25, 2004].
45. McCaffery K, Wardle J, Nadel M, Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002;9:104-108..
46. Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med. 1995;41:365-374.
47. Weller D, Thomas D, Hiller J, Woodward A, Edwards J. Screening for colorectal cancer using an immunochemical test for faecal occult blood: results of the first 2 years of a South Australian programme. Aust N Z J Surg. 1994;64:464-469.
48. Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev. 1997;6:44-52.
49. Hoare T. Breast screening and ethnic minorities. Br J Cancer Suppl. 1996;29:S38-S41.
50. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening - a population-based register study (Sweden). Cancer Causes Control. 2002; 13:73-82.
51. BreastScreen South Australia. 1998 statistical report. Wayville, Australia: BreastScreen South Australia, 2001.
52. BreastScreen Victoria. Annual statistical report, 2000. Carlton South, Australia: BreastScreen Victoria, 2001.
53. BreastScreen Queensland. Queensland health, 2003 [monograph online]. Available from URL: http://www.health.qld.gov.au/breastscreen [accessed Nov 11, 2003].
54. O'Byrne AM, Kavanagh AM, Ugoni A, Diver F. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen. 2000;7:190-194.
55. Clarke V, Jones T. Evaluation of the cervical screening program. Melbourne: Centre for Behavioural Research in Cancer, 1997.
56. Siahpush M, Singh GK. Sociodemographic predictors of pap test receipt, currency and knowledge among Australian women. Prev Med. 2002;35:363-368.
57. Taylor RJ, Mamoon HA, Morrell SL, Wain GV. Cervical screening in migrants to Australia. Aust N Z J Public Health. 2001;25:55-61.
58. Coory MD, Fagan PS, Muller JM, Dunn NA. Participation in cervical cancer screening by women in rural and remote Aboriginal and Torres Strait Islander communities in Queensland. Med J Aust. 2002;177:544-547.
59. Speedy S, Hase S. Health beliefs and perceptions of women presenting or not presenting for mammographic screening in a rural health setting. Aust J Rural Health. 2000;8:208-213.
60. Marteau TM, Hankins M, Collins B. Perceptions of risk of cervical cancer and attitudes towards cervical screening: a comparison of smokers and non-smokers. Fam Pract. 2002; 19:18-22.
61. Fylan F. Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour. Br J Gen Pract. 1998; 48:1509-1514.
62. Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J R Soc Med. 1995;88:389-394.
63. Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J. Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health. 2002;26:236-241.
64. Frew E, Wolstenholme JL, Whynes DK. Willingness-to-pay for colorectal cancer screening. Eur J Cancer. 2001;37:1746-1751.
65. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med. 2000;31:323-334.
66. Cockburn J, White VM, Hirst S, Hill D. Barriers to cervical screening in older women. Aust Fam Physician. 1992;21: 973-978.
67. Crombie IK, Orbell S, Johnston G, Robertson AJ, Kenicer M. Women's experiences at cervical screening. Scott Med J. 1995;40:81-82.
68. Wilson JR, Fazey JA. Self-esteem, compliance, and cervical screening. Psychol Rep. 1995;77:891-898.
69. Yu CK, Rymer J. Women's attitudes to and awareness of smear testing and cervical cancer. Br J Fam Plann. 1998;23: 127-133.
70. McKie L. Women's views of the cervical smear test: implications for nursing practice-women who have had a smear test. J Adv Nurs. 1993;18:1228-1234.
71. Neilson A, Jones RK. Women's lay knowledge of cervical cancer/cervical screening: accounting for non-attendance at cervical screening clinics. J Adv Nurs. 1998;28:571-575.
72. Cockburn J, Schofield P, White V, Hill D, Russell I. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia. J Epidemiol Community Health. 1997;51:62-66.
73. Rimer BK, Briss PA, Zeller PK, Chan E, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214-1228.
74. UK National Screening Committee. Second report of the UK National Screening Committee [monograph online]. Available from URL: http://www.nsc.nhs. uk/pdfs/secondreport.pdf [accessed Mar 25, 2004].
75. Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev. 2003;12:4-13.
76. Olesen F. Detecting cervical cancer: the European experience. Hong Kong Med J. 1999;5:272-274.
77. Hurley SF. Screening: the need for a population register. Med J Aust. 1990;153:310-311.
78. Wait SH, Allemand HM. The French breast cancer screening programme. Epidemiological and economic results of the first round of screening. Eur J Public Health. 1996;6:43-48.
79. Patnick J. Cervical cancer screening in England. Eur J Cancer. 2000;36:2205-2208.